The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease

NCT01002872 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Bone Disease

Interventions

DRUG: Lanthanum Carbonate (Fosrenol)
DRUG: placebo

Sponsor

Endeavor Health

Collaborators

[object Object]